SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-21-055813
Filing Date
2021-11-09
Accepted
2021-11-09 17:13:06
Documents
85
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q flgt-10q_20210930.htm   iXBRL 10-Q 3928643
2 EX-31.1 flgt-ex311_6.htm EX-31.1 20838
3 EX-31.2 flgt-ex312_7.htm EX-31.2 20828
4 EX-32.1 flgt-ex321_9.htm EX-32.1 18203
  Complete submission text file 0001564590-21-055813.txt   13993702

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA flgt-20210930.xsd EX-101.SCH 74556
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE flgt-20210930_cal.xml EX-101.CAL 107143
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE flgt-20210930_def.xml EX-101.DEF 240373
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE flgt-20210930_lab.xml EX-101.LAB 578927
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE flgt-20210930_pre.xml EX-101.PRE 449047
10 EXTRACTED XBRL INSTANCE DOCUMENT flgt-10q_20210930_htm.xml XML 3049027
Mailing Address 4978 SANTA ANITA AVENUE, SUITE 205 TEMPLE CITY CA 91780
Business Address 4978 SANTA ANITA AVENUE, SUITE 205 TEMPLE CITY CA 91780 626-350-0537
Fulgent Genetics, Inc. (Filer) CIK: 0001674930 (see all company filings)

IRS No.: 812621304 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37894 | Film No.: 211393230
SIC: 8071 Services-Medical Laboratories